In addition, Ligand may not be able to successfully implement its strategic growth plan and continue the development of its proprietary programs. no dataThe failure to meet expectations with respect to any of the foregoing matters may reduce Ligand’s stock price. no dataAdditional information concerning these and other risk factors affecting Ligand can be found in prior press releases available at www.ligand.com as well as in Ligand’s public periodic filings with the Securities and Exchange Commission available at www.sec.gov . Ligand disclaims any intent or obligation to update these forward-looking statements beyond the date of this release. This caution is made under the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Other Disclaimers and Trademarks The information in this press release regarding certain third-party products and programs, including Promacta, a Novartis product and Kyprolis, an Amgen product, comes from information publicly released by the owners of such products and programs. Ligand is not responsible for, and has no role in, the development of such products or programs. Ligand owns or has rights to trademarks and copyrights that it uses in connection with the operation of its business including its corporate name, logos and websites. Other trademarks and copyrights appearing in this press release are the property of their respective owners. The trademarks Ligand owns include Ligand, Captisol andOmniAb.
For the original version including any supplementary images or video, visit http://finance.yahoo.com/news/ligand-reports-third-quarter-2016-200100220.html
Carr Odin Ophthalmol. 2013;246:589-97. Causes of uveitis in the general practice of ophthalmology. Learn More Increased sensitivity to light Uveitis may develop rapidly, and it is very important that you see your eye doctor for a complete eye exam if you develop these symptoms, especially if a painful, red eye does not clear up quickly. It produces swelling, redness, heat, and destroys tissues as certain white blood cells rush to the affected part of the body to contain or eliminate the insult. Iritis affects the front of your eye. Located between the sclera, the eye’s white outer coat, and the inner layer of the eye, called the retina, the urea consists of the iris, biliary body, and choroid: Iris: The coloured circle at the front of the eye. The iris regulates the amount of light that enters the eye, the biliary body produces aqueous humour and supports the lens, and the choroid provides oxygen and nourishment for the retina. Treatment for uveitis includes medications and regular eye care to monitor the disorder. Uveitis is often grouped by the part of the urea it affects. The most common side effects noted during those studies were cataract progression, increased intra ocular pressure, procedural complications and eye pain. Classification, symptoms, and signs of uveitis. Keratitic precipitates white blood cells on the endothelium are a hallmark of iritis. A doctor must make sure a patient is not fighting an infection before proceeding with these therapies.